ResMed Gross Profit 2010-2024 | RMD

ResMed annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • ResMed gross profit for the quarter ending March 31, 2024 was $0.693B, a 12.15% increase year-over-year.
  • ResMed gross profit for the twelve months ending March 31, 2024 was $2.557B, a 13.11% increase year-over-year.
  • ResMed annual gross profit for 2023 was $2.356B, a 16.37% increase from 2022.
  • ResMed annual gross profit for 2022 was $2.024B, a 10.07% increase from 2021.
  • ResMed annual gross profit for 2021 was $1.839B, a 7.06% increase from 2020.
ResMed Annual Gross Profit
(Millions of US $)
2023 $2,356
2022 $2,024
2021 $1,839
2020 $1,718
2019 $1,494
2018 $1,335
2017 $1,202
2016 $1,066
2015 $1,011
2014 $990
2013 $941
2012 $821
2011 $741
2010 $655
2009 $554
ResMed Quarterly Gross Profit
(Millions of US $)
2024-03-31 $693
2023-12-31 $647
2023-09-30 $600
2023-06-30 $617
2023-03-31 $618
2022-12-31 $580
2022-09-30 $541
2022-06-30 $523
2022-03-31 $491
2021-12-31 $504
2021-09-30 $506
2021-06-30 $491
2021-03-31 $447
2020-12-31 $462
2020-09-30 $439
2020-06-30 $449
2020-03-31 $450
2019-12-31 $427
2019-09-30 $392
2019-06-30 $395
2019-03-31 $381
2018-12-31 $375
2018-09-30 $343
2018-06-30 $335
2018-03-31 $344
2017-12-31 $350
2017-09-30 $306
2017-06-30 $324
2017-03-31 $300
2016-12-31 $309
2016-09-30 $269
2016-06-30 $301
2016-03-31 $260
2015-12-31 $267
2015-09-30 $239
2015-06-30 $259
2015-03-31 $251
2014-12-31 $263
2014-09-30 $237
2014-06-30 $261
2014-03-31 $252
2013-12-31 $249
2013-09-30 $228
2013-06-30 $260
2013-03-31 $239
2012-12-31 $233
2012-09-30 $209
2012-06-30 $226
2012-03-31 $210
2011-12-31 $199
2011-09-30 $185
2011-06-30 $199
2011-03-31 $183
2010-12-31 $186
2010-09-30 $174
2010-06-30 $175
2010-03-31 $167
2009-12-31 $164
2009-09-30 $150
2009-06-30 $157
2009-03-31 $139
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $28.121B $4.223B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $180.765B 23.67
Stryker (SYK) United States $129.618B 31.05
Boston Scientific (BSX) United States $112.981B 35.99
Medtronic (MDT) Ireland $100.927B 15.11
EssilorLuxottica (ESLOY) France $99.128B 0.00
Lonza Group Ag (LZAGY) Switzerland $40.585B 0.00
Haleon (HLN) United Kingdom $37.716B 27.53
Terumo (TRUMY) Japan $24.403B 34.46
Koninklijke Philips (PHG) Netherlands $22.841B 18.13
Zimmer Biomet Holdings (ZBH) United States $22.328B 14.26
Baxter (BAX) United States $17.045B 12.12
Insulet (PODD) United States $14.134B 62.67
Smith & Nephew SNATS (SNN) United Kingdom $10.833B 0.00
Demant (WILYY) Denmark $9.370B 0.00
Bio-Rad Laboratories (BIO) United States $7.790B 25.48
BellRing Brands (BRBR) United States $7.453B 35.06
Lantheus Holdings (LNTH) United States $5.565B 13.87
GN Store Nord (GNNDY) Denmark $4.222B 23.71
Haemonetics (HAE) United States $4.215B 20.79
Perrigo (PRGO) Ireland $3.501B 10.61
Prestige Consumer Healthcare (PBH) United States $3.437B 16.35
Neogen (NEOG) United States $3.386B 32.56
ICU Medical (ICUI) United States $2.893B 25.54
Envista Holdings (NVST) United States $2.858B 11.79
TG Therapeutics (TGTX) United States $2.749B 77.35
Green Thumb Industries (GTBIF) United States $2.552B 49.96
Agios Pharmaceuticals (AGIO) United States $2.448B 0.00
QuidelOrtho (QDEL) United States $2.225B 12.35
LeMaitre Vascular (LMAT) United States $1.847B 54.13
Maravai LifeSciences Holdings (MRVI) United States $1.804B 0.00
Warby Parker (WRBY) United States $1.592B 0.00
InMode (INMD) Israel $1.532B 8.14
AdaptHealth (AHCO) United States $1.332B 9.90
Verano Holdings (VRNOF) United States $1.246B 0.00
AtriCure (ATRC) United States $1.084B 0.00
Owens & Minor (OMI) United States $1.033B 9.00
National Vision Holdings (EYE) United States $1.028B 32.72
BioLife Solutions (BLFS) United States $0.987B 0.00
Cresco Labs (CRLBF) United States $0.771B 0.00
Phibro Animal Health (PAHC) United States $0.679B 14.46
Evolus (EOLS) United States $0.679B 0.00
PetIQ (PETQ) United States $0.656B 21.21
VAREX IMAGING (VREX) United States $0.602B 14.16
Surmodics (SRDX) United States $0.599B 37.54
Quanterix (QTRX) United States $0.506B 0.00
ZimVie (ZIMV) United States $0.498B 42.44
Canopy Growth (CGC) Canada $0.491B 0.00
Valneva SE (VALN) France $0.488B 0.00
Biote (BTMD) United States $0.463B 10.67
Jin Medical (ZJYL) China $0.403B 0.00
TerrAscend (TSNDF) Canada $0.394B 0.00
Cerus (CERS) United States $0.325B 0.00
OraSure Technologies (OSUR) United States $0.315B 10.14
Zynex (ZYXI) United States $0.296B 40.52
MacroGenics (MGNX) United States $0.266B 0.00
Viemed Healthcare (VMD) United States $0.254B 25.19
Aurora Cannabis (ACB) Canada $0.252B 0.00
Sanara MedTech (SMTI) United States $0.243B 0.00
Utah Medical Products (UTMD) United States $0.236B 14.85
Omeros (OMER) United States $0.235B 0.00
Ayr Wellness (AYRWF) United States $0.233B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Holdings (OGI) Canada $0.160B 0.00
FitLife Brands (FTLF) United States $0.153B 21.76
Capricor Therapeutics (CAPR) United States $0.153B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
Quipt Home Medical (QIPT) United States $0.137B 0.00
Veru (VERU) United States $0.123B 0.00
Jushi Holdings (JUSHF) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.104B 0.00
Fonar (FONR) United States $0.101B 10.26
Brainsway (BWAY) Israel $0.101B 0.00
InterCure (INCR) Israel $0.092B 15.46
Cellectar Biosciences (CLRB) United States $0.090B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.073B 4.75
MariMed (MRMD) United States $0.069B 0.00
Safety Shot (SHOT) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.053B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Zevia PBC (ZVIA) United States $0.049B 0.00
Bright Green (BGXX) United States $0.048B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Apyx Medical (APYX) United States $0.046B 0.00
United-Guardian (UG) United States $0.041B 14.90
Cytosorbents (CTSO) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Exagen (XGN) United States $0.032B 0.00
Nephros (NEPH) United States $0.022B 0.00
Meihua Medical Technologies (MHUA) China $0.021B 0.00
Agape ATP (ATPC) $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.016B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
FSD PHARMA (HUGE) Canada $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.001B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00